Clinical Trial Update: A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating novel agents or combinations as perioperative treatment for locally advanced, resectable gastroesophageal adenocarcinoma; curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Adenocarcinoma

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Adenocarcinoma | Phase 2 | Status: RECRUITING